CASDIN CAPITAL, LLC
Adviser information for CASDIN CAPITAL, LLC last updated from Form ADV on March 30th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Liability Company |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 33 |
---|---|
Investment Advisory/Research | 12 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 8 | $2.6B |
Non-Discretionary | 0 | $0 |
Total | 8 | $2.6B |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 8 | $2.6B |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 25 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
1350 AVENUE OF THE AMERICASSUITE 2600
NEW YORK
NY
United States
Monday - Friday, 8:30AM - 5:00PM
Tel: 212.897.5430, Fax: None
Chief Compliance Officer
ANGELO CRUPI
CHIEF COMPLIANCE OFFICER
1350 AVENUE OF THE AMERICAS
SUITE 2600
NEW YORK
NY
United States
Tel:
212-554-4959
A*****@****************M
(Full email address available in API data)
Regulatory Contact
STEVEN MICHAEL GIORDANO
GENERAL COUNSEL
1350 AVENUE OF THE AMERICAS
SUITE 2600
NEW YORK
NY
United States
Tel:
646-661-3886
S****@****************M
(Full email address available in API data)
Industry Affiliates
CASDIN PARTNERS GP, LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC | Sponsor, GP, manager of pooled investment vehicles |
CASDIN PRIVATE GROWTH EQUITY FUND II GP, LLC | Sponsor, GP, manager of pooled investment vehicles |
CASDIN VENTURE OPPORTUNITIES FUND GP, LLC | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
CASDIN AMPLIFY FUND, LP | Hedge Fund | $13.6M | $10.0M | 2 |
CASDIN PARTNERS FO1 - MSV, LP | Hedge Fund | $24.6M | $0.0M | 2 |
CASDIN PARTNERS MASTER FUND, L.P. | Hedge Fund | $1,931.5M | $1.0M | 563 |
CASDIN PRIVATE GROWTH EQUITY FUND II, L.P. | Private Equity Fund | $402.0M | $1.0M | 226 |
CASDIN PRIVATE GROWTH EQUITY FUND, L.P. | Private Equity Fund | $243.5M | $1.0M | 175 |
CASDIN VENTURE OPPORTUNITIES FUND, L.P. | Venture Capital Fund | $28.5M | $1.0M | 46 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
CASDIN, ELI, D | Individual | – | MANAGING MEMBER | 08/2011 | > 75% |
CANZONERI, LAWRENCE, JUDE | Individual | – | CHIEF FINANCIAL OFFICER | 05/2019 | < 5% |
FISK, ALEXANDRIA | Individual | – | CHIEF OPERATING OFFICER | 01/2020 | < 5% |
CRUPI, ANGELO | Individual | – | CHIEF COMPLIANCE OFFICER | 03/2021 | < 5% |
GIORDANO, STEVEN, MICHAEL | Individual | – | GENERAL COUNSEL | 03/2022 | < 5% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
2SEVENTY BIO INC | COMMON STOCK | 8M | 2M | – |
4D MOLECULAR THERAPEUTICS IN | COM | 17M | 800K | – |
ABSCI CORPORATION | COM | 3M | 973K | – |
ALNYLAM PHARMACEUTICALS INC | COM | 41M | 170K | – |
AVIDITY BIOSCIENCES INC | COM | 85M | 2M | – |
BEAM THERAPEUTICS INC | COM | 16M | 675K | – |
BIOLIFE SOLUTIONS INC | COM NEW | 187M | 9M | – |
BLUEPRINT MEDICINES CORP | COM | 35M | 326K | – |
CENTURY THERAPEUTICS INC | COM | 8M | 3M | – |
CODEXIS INC | COM | 6M | 2M | – |
CONTINEUM THERAPEUTICS INC | CL A | 5M | 297K | – |
DENALI THERAPEUTICS INC | COM | 30M | 1M | – |
EXACT SCIENCES CORP | COM | 27M | 650K | – |
EXSCIENTIA PLC | ADS | 1M | 214K | – |
GENEDX HOLDINGS CORP | COM CL A | 92M | 4M | – |
GINKGO BIOWORKS HOLDINGS INC | CL A SHS | 488K | 1M | – |
GRAIL INC | COM | 1M | 80K | – |
GUARDANT HEALTH INC | COM | 3M | 100K | – |
ILLUMINA INC | COM | 50M | 480K | – |
INTELLIA THERAPEUTICS INC | COM | 45M | 2M | – |
KRONOS BIO INC | COM | 154K | 124K | – |
KYVERNA THERAPEUTICS INC | COM | 4M | 575K | – |
MONTE ROSA THERAPEUTICS INC | COM | 976K | 261K | – |
NEUROGENE INC | COM | 19M | 525K | – |
PACIFIC BIOSCIENCES CALIF IN | COM | 1M | 1M | – |
PLIANT THERAPEUTICS INC | COM | 11M | 1M | – |
PRIME MEDICINE INC | COM | 2M | 367K | – |
RELAY THERAPEUTICS INC | COM | 55M | 8M | – |
REVOLUTION MEDICINES INC | COM | 171M | 4M | – |
SAREPTA THERAPEUTICS INC | COM | 170M | 1M | – |
SINGULAR GENOMICS SYSTEMS IN | COM NEW | 373K | 44K | – |
STANDARD BIOTOOLS INC | COM | 113M | 64M | – |
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 27M | 700K | – |
SYNDAX PHARMACEUTICALS INC | COM | 3M | 150K | – |
TANGO THERAPEUTICS INC | COM | 10M | 1M | – |
TENAYA THERAPEUTICS INC | COM | 21M | 7M | – |
VERACYTE INC | COM | 19M | 858K | – |
VERVE THERAPEUTICS INC | COM | 15M | 3M | – |